USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evonik Degussa Gmbh

USPTO PatentsView assignee record - 686 granted patents across 125 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).

686
Total patents granted
125
CPC technology areas
15.6
Avg claims per patent
-97%
5-year filing velocity

The verdict

Evonik holds 686 US patents across 125 technology areas, rank #653 of 50,000 tracked assignees.

#653
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.9/100)
15.6
avg claims per patent
-97%
filing velocity, last 5 yrs

Portfolio overview

Evonik Degussa Gmbh has been granted 686 US utility patents between 2015 and 2021, placing Evonik Degussa Gmbh at rank #653 across all assignees tracked by PlainPatent. This portfolio spans 125 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Evonik Degussa Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Evonik sits between Rivian IP Holdings, Llc (690 patents, rank #649) and Tianma Microelectronics Co., Ltd. (684 patents, rank #657) - the closest US assignees by grant volume. The composite Innovation Score of 56.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 23 grants, compared with 663 in the 2015–2019 window, a -97% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Evonik Degussa Gmbh's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Evonik Degussa Gmbh against peers pursuing similar technology classes.

Who files at Evonik's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Evonik holds 686 patents at rank #653, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Evonik

By rank, the assignees closest to #653 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Evonik's primary technology class.

Evonik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

-50050100150200 2015201620172018201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Evonik Degussa Gmbh patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 118 17.2%
2016 92 13.4%
2017 142 20.7%
2018 157 22.9%
2019 154 22.4%
2020 22 3.2%
2021 1 0.1%

Which technologies does Evonik Degussa Gmbh patent most?

Top 15 of 125 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Diversified
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#653

Across all tracked assignees

Innovation Score

56.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Evonik Degussa Gmbh hold?
Evonik Degussa Gmbh holds 686 US granted patents filed between 2015 and 2021, spanning 125 technology areas.
What is Evonik Degussa Gmbh's Innovation Score?
Evonik Degussa Gmbh has an Innovation Score of 56.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Evonik Degussa Gmbh focus on?
Evonik Degussa Gmbh's top technology area is C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS) with 193 patents. The company has filed patents in 125 CPC subclasses total.
Is Evonik Degussa Gmbh's patent filing rate increasing or decreasing?
Evonik Degussa Gmbh's recent filing velocity is -97% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Evonik Degussa Gmbh's patents?
Evonik Degussa Gmbh's patents average 15.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Evonik Degussa Gmbh patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Evonik's 686 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Evonik ranks #653 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C07C - see who else leads that technology area. C07C leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.